https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18606 Sat 24 Mar 2018 08:01:03 AEDT ]]> p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32265 Mon 23 Sep 2019 13:56:46 AEST ]]> Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34339 Mon 03 Feb 2020 11:52:07 AEDT ]]>